biological source
human cervix
packaging
tube of 5 μg 95091409-DNA-5UG, pkg of vial of cells 95091409-1VL
growth mode
Adherent
karyotype
Not specified
morphology
Epithelial-like
products
Not specified
receptors
Not specified
technique(s)
cell culture | mammalian: suitable
relevant disease(s)
cancer
shipped in
dry ice
storage temp.
−196°C
Application
Gene expression and activation studies
Biochem/physiol Actions
HR5 cells were obtained after transfection of HeLa cells with plasmids coding for a reverse tetracycline-controlled transactivator encoding a nuclear localisation sequence (rt TA-nls) and transferring G418 resistance. This transactivator (a fusion between the Tet repressor and the activating domain of the herpes simplex virus VP16 transcription activation domain) can stimulate the expression of a reporter gene up to 10E5-fold. HR5 is the parent cell line for HR5-CL11 (Sigma Catalogue number.95091411).
Human cervix carcinoma, HeLa derivative, transformed
Preparation Note
DMEM + 2mM Glutamine + 10% Foetal Bovine Serum (FBS).
Split sub-confluent cultures (70-80%) 1:5 to 1:20 i.e. seeding at 2x1,000 to 2x10,000 cells/cm2 using 0.25% trypsin or trypsin/EDTA; 5% CO2; 37°C.
Other Notes
Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.
法规信息
新产品
此项目有
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持